Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
18 to 75
Other
KMU-IRB00003151
VGHKS95-CT3-11, NCT00656968
2.
Nexium Study To Suppress Nausea During Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
H-16348
Nexium Study, NCT00206440
Last Modified:
5/15/2008
 
First Published:
7/23/2006
3.
Phase III Randomized Chemoprevention Study of Esomeprazole With Versus Without Acetylsalicyclic Acid (Aspirin) in Preventing Esophageal Cancer in Patients With Barrett's Metaplasia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Biomarker/Laboratory analysis, Prevention
Active
18 and over
Other, Pharmaceutical / Industry
OCTO-ASPECT
RADCLIFFE-32, ZENECA-RADCLIFFE-32, EUDRACT-2004-003836-77, ISRCTN85156844, EU-20628, NCT00357682
Last Modified:
10/20/2008
 
First Published:
5/11/2007
4.
Phase II Randomized Chemoprevention Study of Esomeprazole Magnesium With Versus Without Acetylsalicylic Acid (Aspirin) in Patients With Barrett Esophagus
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Prevention
Active
18 and over
NCI
MAYO-MAY04-4-01
MAY04-4-01, NCT00474903
5.
APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
18 and over
Other
D9612L00088
NCT00546065
6.
Evaluation of Esomeprazole in Treating Gastro-Esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Active
18 and over
Other
200308067
NCT00222079
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute